Ulrich RODECK

Person

Philadelphia, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CTLA4-binding protein peptide-linker masks
- Patent number 11,926,652
- Issue date Mar 12, 2024
- City of Hope
- John Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Development of masked therapeutic antibodies to limit off-target ef...
- Patent number 11,311,622
- Issue date Apr 26, 2022
- City of Hope
- John C. Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-selective CTLA-4 antagonists
- Patent number 11,279,752
- Issue date Mar 22, 2022
- City of Hope
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Development of masked therapeutic antibodies to limit off-target ef...
- Patent number 11,186,642
- Issue date Nov 30, 2021
- City of Hope
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CTLA4-binding protein peptide-linker masks
- Patent number 10,689,423
- Issue date Jun 23, 2020
- City of Hope
- John Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-selective CTLA-4 antagonists
- Patent number 10,414,814
- Issue date Sep 17, 2019
- City of Hope
- John C. Williams
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Development of masked therapeutic antibodies to limit off-target ef...
- Patent number 10,357,571
- Issue date Jul 23, 2019
- Thomas Jefferson University
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Development of masked therapeutic antibodies to limit off-target ef...
- Patent number 8,895,702
- Issue date Nov 25, 2014
- City of Hope
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
WT1 monoclonal antibodies and methods of use therefor
- Patent number 5,633,142
- Issue date May 27, 1997
- The Wistar Institute of Anatomy and Biology
- Meenhard Herlyn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
WT1 monoclonal antibodies
- Patent number 5,622,835
- Issue date Apr 22, 1997
- The Wistar Institute of Anatomy and Biology
- Meenhard Herlyn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating human EGF receptor-expressing gliomas using radi...
- Patent number 5,470,571
- Issue date Nov 28, 1995
- The Wistar Institute
- Meenhard Herlyn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ISOFORM SPECIFIC AGONISTS TARGETING AKT KINASE
- Publication number 20240325340
- Publication date Oct 3, 2024
- Thomas Jefferson University
- Roger S. Armen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...
- Publication number 20230085485
- Publication date Mar 16, 2023
- CITY OF HOPE
- John C. Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CTLA4-BINDING PROTEIN PEPTIDE-LINKER MASKS
- Publication number 20210122795
- Publication date Apr 29, 2021
- CITY OF HOPE
- John WILLIAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-SELECTIVE CTLA-4 ANTAGONISTS
- Publication number 20200325212
- Publication date Oct 15, 2020
- CITY OF HOPE
- John C. WILLIAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...
- Publication number 20200164077
- Publication date May 28, 2020
- Thomas Jefferson University
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CTLA4-BINDING PROTEIN PEPTIDE-LINKER MASKS
- Publication number 20190169245
- Publication date Jun 6, 2019
- CITY OF HOPE
- John WILLIAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR-SELECTIVE CTLA-4 ANTAGONISTS
- Publication number 20180215806
- Publication date Aug 2, 2018
- CITY OF HOPE
- John C. WILLIAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EF...
- Publication number 20170218074
- Publication date Aug 3, 2017
- CITY OF HOPE
- John C. WILLIAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...
- Publication number 20160152711
- Publication date Jun 2, 2016
- CITY OF HOPE
- John C. WILLIAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...
- Publication number 20130150558
- Publication date Jun 13, 2013
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EF...
- Publication number 20110178279
- Publication date Jul 21, 2011
- John C. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Masking Ligands For Reversible Inhibition Of Multivalent Compounds
- Publication number 20100189727
- Publication date Jul 29, 2010
- Tegopharm Corporation
- Ulrich Rodeck
- C07 - ORGANIC CHEMISTRY

Ulrich RODECK

Person

Patents Grantslast 30 patents

CTLA4-binding protein peptide-linker masks

Development of masked therapeutic antibodies to limit off-target ef...

Tumor-selective CTLA-4 antagonists

Development of masked therapeutic antibodies to limit off-target ef...

CTLA4-binding protein peptide-linker masks

Tumor-selective CTLA-4 antagonists

Development of masked therapeutic antibodies to limit off-target ef...

Development of masked therapeutic antibodies to limit off-target ef...

WT1 monoclonal antibodies and methods of use therefor

WT1 monoclonal antibodies

Method of treating human EGF receptor-expressing gliomas using radi...

Patents Applicationslast 30 patents

ISOFORM SPECIFIC AGONISTS TARGETING AKT KINASE

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...

CTLA4-BINDING PROTEIN PEPTIDE-LINKER MASKS

TUMOR-SELECTIVE CTLA-4 ANTAGONISTS

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...

CTLA4-BINDING PROTEIN PEPTIDE-LINKER MASKS

TUMOR-SELECTIVE CTLA-4 ANTAGONISTS

DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EF...

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OF...

DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EF...

Masking Ligands For Reversible Inhibition Of Multivalent Compounds